Related Experiment Video
Updated: May 11, 2026

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
Published on: October 17, 2013
An On-demand Morphing Impeller Pump for Low-Speed, Hemocompatible pVADs
Xiaolong Chen1, Zhenyan Zhu1, Yanxi Chen1
1School of Mechanical Engineering, Tongji University, Shanghai, China.
Abstract:
Percutaneous ventricular assist devices (pVADs) are vital for acute cardiogenic shock, yet their performance is limited by the small delivery profile required for femoral access. This constraint restricts impeller size and necessitates ultra-high rotational speeds for adequate blood flow, which in turn increases hemolysis risk. Here we present the on-demand Morphing Flexible Impeller Pump (MFP), which mitigates this trade-off via an integrated deployable linkage system inspired by umbrella opening mechanisms. This system converts simple pushing force into complex spatial deformation of the pump's flexible blades, allowing the MFP to transition from a 7 mm-diameter catheter-deliverable profile to a 16 mm-diameter helical pumping configuration in situ. The enlarged pumping geometry achieves a clinically relevant pressure gradient of 10 mmHg at 4000 rpm, markedly lower than reported speeds of typical micro-axial pumps. CFD analyses showed that shear stresses were largely below the hemolysis-related threshold (150 Pa), with minimal high-stress volumes. Consistently, in vitro experiments showed hemolysis indices comparable to clinically used pumps (e.g., Impella CP) under matched hemodynamic conditions. By decoupling delivery size from pumping capacity, this morphing-impeller strategy offers a promising route toward safer and more efficient minimally invasive circulatory support.
More Related Videos
Related Concept Videos
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Rate-Programmed I

